University of Miami/Sylvester Cancer Center
Locations
Transplant Summary
Overview
The University of Miami Sylvester Cancer Center is an NCI Designated Cancer Center. The Adult Stem Cell Transplant Program was founded in 1992 and is FACT accredited. The program provides comprehensive, multidisciplinary care for patients requiring autologous and allogeneic stem cell transplants and immune effector cell therapies. This care is provided in an academic environment with inpatient and outpatient facilities optimized for the care of stem cell therapy recipients.This center has been performing allogeneic transplants since 1994 and has been an NMDP transplant center since December 2001.
Attending physicians
Adult - Amer Beitinjaneh, Mark Goodman, Damian Green, Noa Holzman, Antonio Jimenez, Lazaros Lekakis, Denise Pereira, Jay Spiegel, Trent WangTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult onlyOther programs and services
Discounts with local hotels. Pre-transplant patients and their caregivers are required to attend one of our Zoom Meet and Greet Meetings which is offered monthly in English and Spanish. These meetings are run by a multidisciplinary team to provide information regarding transplant and allow future patients to meet some of our former patients.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 188 patients.The actual 1-year survival of these patients is 74.9%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 67.9% and 79.9%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
297
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow1PBSC28Cord blood0Total29Unrelated donorMarrow3PBSC92Cord blood0Total95Total allogeneicMarrow4PBSC120Cord blood0Total124AutologousMarrowBoth marrow & PBSC 173PBSC—Cord blood—Total173Total combinedMarrowBoth marrow & PBSC 297PBSC—Cord blood0Total297All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-441145-641365+5Total29Unrelated 0-18019-442145-644365+31Total95Autologous 0-18019-443045-649365+50Total173Total 0-18019-446245-6414965+86Total297Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Sylvester Comprehensive Cancer Center
1475 NW 12 Ave Miami, FL 33136 Phone:305-243-1000 Staff
Program Director:Trent Wang, MDProgram Coordinator:Daniela Vaccino, RNMedical Specialties in Program
Allergy/immunology, cardiology, complementary and alternative medicine, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, urology.Medical Services Offered
Chronic GVHD management, financial counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic and Autologous transplant recipients
- Adults: 3 months after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital